CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EXPEDITE focuses on improving gene therapy by integrating therapeutic DNA at specific genomic locations. It aims to address limitations of current adeno-associated viral vector therapies for treating genetic diseases.
In vivo gene therapy based on a single administration of adeno-associated viral (AAV) vectors is emerging as an effective therapeutic option for both monogenic and complex diseases.
Given the episomal nature of the AAV genome, its applications are limited to non-replicating tissues like retina or adult liver.
Several AAV-based products that target these tissues are either approved or in advanced clinical development.
Despite this, some limitations still remain, including: the potential for inser…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Pozzuoli
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Italy, Napoli
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
NEXT GENERATION DIAGNOSTIC SRL
Italy, Pozzuoli
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
